New Advances in the Diagnosis and Management of Musculoskeletal Pain

This symposium will highlight some of the latest advancements in musculoskeletal pain, spanning novel pain mechanisms and treatments, clinical phenotyping and implementation science. It features a series of talks by global leaders in our field and some of our most promising emerging researchers.
The program will begin with four 30-minute plenary talks. Eva Kosek (Karolinska Institute, Sweden, ) will discuss advancements in back pain phenotyping (BACPAP initiative), crucial for personalized treatment. Wade Kingery & David Clark (Stanford University, USA) will then explore the role of autoantibodies in osteoarthritis and back pain, offering new mechanistic insights and highlighting opportunities for novel therapeutics.
Following this, Vicky Chapman (University of Nottingham, UK) will present on soluble epoxide hydrolase as a potential new therapeutic target for osteoarthritis pain. Finally, Martjie Venter (UNSW, Australia) will address the practical implementation of effective non-drug care for back pain within healthcare systems.
After a short break, three 10-minute talks will be presented by our trainee and early career researcher abstract award winners. This symposium will offer a broad overview of key advancements and emerging research in musculoskeletal pain, and will be of interest to basic scientists, clinical researchers, and clinicians alike.